These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 16389653)

  • 1. A preference-based index for the SF-12.
    Stratmann-Schoene D; Kuehn T; Kreienberg R; Leidl R
    Health Econ; 2006 Jun; 15(6):553-64. PubMed ID: 16389653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An investigation into the empirical validity of the EQ-5D and SF-6D based on hypothetical preferences in a general population.
    Petrou S; Hockley C
    Health Econ; 2005 Nov; 14(11):1169-89. PubMed ID: 15942981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The performance of a value set for the EQ-5D based on experienced health states in patients with inflammatory bowel disease.
    Leidl R; Reitmeir P; König HH; Stark R
    Value Health; 2012 Jan; 15(1):151-7. PubMed ID: 22264983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Portuguese value set for the SF-6D.
    Ferreira LN; Ferreira PL; Pereira LN; Brazier J; Rowen D
    Value Health; 2010 Aug; 13(5):624-30. PubMed ID: 20230545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preference-based index measurement of health-related quality of life: when does it reflect only arbitrary settings of the researcher?
    Konerding U
    Health Econ; 2011 Apr; 20(4):471-83. PubMed ID: 21394817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are decisions using cost-utility analyses robust to choice of SF-36/SF-12 preference-based algorithm?
    Pickard AS; Wang Z; Walton SM; Lee TA
    Health Qual Life Outcomes; 2005 Mar; 3():11. PubMed ID: 15748287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can health utility measures be used in lupus research? A comparative validation and reliability study of 4 utility indices.
    Moore AD; Clarke AE; Danoff DS; Joseph L; Bélisle P; Neville C; Fortin PR
    J Rheumatol; 1999 Jun; 26(6):1285-90. PubMed ID: 10381044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The burden of depressive disorders in Germany - results from the European Study of the Epidemiology of Mental Disorders (ESEMeD)].
    Günther OH; Friemel S; Bernert S; Matschinger H; Angermeyer MC; König HH
    Psychiatr Prax; 2007 Sep; 34(6):292-301. PubMed ID: 17806016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective evaluation of preferences and quality of life in women with hip fractures.
    Cranney AB; Coyle D; Hopman WM; Hum V; Power B; Tugwell PS
    J Rheumatol; 2005 Dec; 32(12):2393-9. PubMed ID: 16331770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the EQ-5D and SF-6D across seven patient groups.
    Brazier J; Roberts J; Tsuchiya A; Busschbach J
    Health Econ; 2004 Sep; 13(9):873-84. PubMed ID: 15362179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The estimation of a preference-based measure of health from the SF-12.
    Brazier JE; Roberts J
    Med Care; 2004 Sep; 42(9):851-9. PubMed ID: 15319610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimation of a valuation function for a diabetes mellitus-specific preference-based measure of health: the Diabetes Utility Index.
    Sundaram M; Smith MJ; Revicki DA; Miller LA; Madhavan S; Hobbs G
    Pharmacoeconomics; 2010; 28(3):201-16. PubMed ID: 20151725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis.
    Marra CA; Woolcott JC; Kopec JA; Shojania K; Offer R; Brazier JE; Esdaile JM; Anis AH
    Soc Sci Med; 2005 Apr; 60(7):1571-82. PubMed ID: 15652688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of minimum clinically important difference (MCID) in pain, disability, and quality of life after revision fusion for symptomatic pseudoarthrosis.
    Parker SL; Adogwa O; Mendenhall SK; Shau DN; Anderson WN; Cheng JS; Devin CJ; McGirt MJ
    Spine J; 2012 Dec; 12(12):1122-8. PubMed ID: 23158968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective analysis of clinical evaluation and self-assessment by patients after decompression surgery for degenerative lumbar canal stenosis.
    Haro H; Maekawa S; Hamada Y
    Spine J; 2008; 8(2):380-4. PubMed ID: 17433781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling SF-6D Hong Kong standard gamble health state preference data using a nonparametric Bayesian method.
    Kharroubi SA; Brazier JE; McGhee S
    Value Health; 2013; 16(6):1032-45. PubMed ID: 24041353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrating preferences into health status assessment for amyotrophic lateral sclerosis: the ALS Utility Index.
    Beusterien K; Leigh N; Jackson C; Miller R; Mayo K; Revicki D
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2005 Sep; 6(3):169-76. PubMed ID: 16183558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A social preference valuations set for EQ-5D health states in Flanders, Belgium.
    Cleemput I
    Eur J Health Econ; 2010 Apr; 11(2):205-13. PubMed ID: 19582490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility and reliability of a mailed questionnaire to obtain visual analogue scale valuations for health states defined by the Health Utilities Index Mark 3.
    Raat H; Bonsel GJ; Hoogeveen WC; Essink-Bot ML;
    Med Care; 2004 Jan; 42(1):13-8. PubMed ID: 14713735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.